Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS

BACKGROUND: We explored the effect of teriflunomide on cortical gray matter (CGM) and whole brain (WB) atrophy in patients with clinically isolated syndrome (CIS) from the phase III TOPIC study and assessed the relationship between atrophy and risk of conversion to clinically definite MS (CDMS). MET...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ther Adv Neurol Disord
Päätekijät: Zivadinov, Robert, Dwyer, Michael G., Carl, Ellen, Poole, Elizabeth M., Cavalier, Steve, Briassouli, Paraskevi, Bergsland, Niels
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2020
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7672760/
https://ncbi.nlm.nih.gov/pubmed/33240397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420970754
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia